Aims To evaluate the efficacy and safety of celecoxib in patients with osteoarthritis who previously failed naproxen and ibuprofen ... trials of celecoxib 200 mg daily were undertaken in patients ...

Indeed, the government's Agency for Healthcare Research and Quality now says that naproxen is less likely than other NSAIDs to harm the heart. And the AHA says celecoxib should be used to treat ...

The objective is to compare patients' assessments of arthritis pain (visual analog scale [VAS]) after 6 weeks of celecoxib 200 mg once daily (q.d.) or placebo. † Calculated based on the number ...